B4GALT1

B4GALT1, also known as UDP-galactose:N-acetylglucosamine beta-1,4-N-acetylglucosaminyltransferase I, is an enzyme encoded by the B4GALT1 gene in humans. This enzyme is a key player in the biosynthesis of complex and lactosamine-type N-glycans. It catalyzes the transfer of galactose from UDP-galactose to an N-acetylglucosamine residue. This specific glycosylation step is crucial for the proper formation of various glycoproteins and glycolipids found on cell surfaces.

The B4GALT1 enzyme is a type II membrane protein and is primarily localized in the Golgi apparatus. Its activity is essential for the expression of certain blood group antigens, such as the B antigen. Aberrant expression or mutations in B4GALT1 have been linked to a range of congenital disorders of glycosylation (CDGs) and other health conditions. For instance, defects in this enzyme can lead to severe neurological and developmental problems. Research into B4GALT1 continues to shed light on the intricate pathways of glycosylation and its impact on human health and disease. Understanding its function is vital for developing diagnostic tools and therapeutic strategies for glycosylation-related disorders.